Alvogen
Alvogen, headquartered in Morristown, New Jersey, specializes in developing, manufacturing, and marketing a diverse range of pharmaceutical products, with a strong focus on complex formulations and strategic 505(b)(2) products.
Company Headquarters and Manufacturing Facilities
Alvogen is headquartered in Morristown, New Jersey. The company has significant in-house manufacturing capacity located in Norwich, NY. The Norwich facility extends from the foundation of Norwich Pharmaceutical Services and boasts a 130-year history in pharmaceutical manufacturing.
Product Portfolio and Research & Development
Alvogen offers a portfolio of over 50 products currently on the market. The company places a strong emphasis on extensive research and development capabilities, which support a growing pipeline of pharmaceutical products. The development, in-licensing, manufacturing, and marketing of complex inhalation products, injectables, and strategic 505(b)(2) products are key focuses.
Subsidiaries and Business Divisions
Alvogen operates through several subsidiaries, including Alvogen Generic Business, Almatica Brand Products, Almaject Injectables, and Norwich US-based manufacturing. These subsidiaries specialize in various aspects of pharmaceutical product development, manufacturing, and marketing.
Academic Partnerships and Collaborations
Alvogen actively engages in academic partnerships and values collaboration for strategic growth and innovation. The company participates in the MIT Industrial Liaison Program and collaborates with Columbia University on the Life Course Project. These partnerships aim to foster innovation and advance pharmaceutical science.
Commitment to Patient Safety
Patient safety is a fundamental commitment for Alvogen. The company employs a pharmacovigilance system to monitor the benefits and risks of medications throughout their lifecycle. This system aims to ensure patients' safety by identifying and mitigating any potential risks associated with the use of Alvogen’s pharmaceutical products.